Evidence map›Paper›PMID 25675143›Full record

ReviewHuman gene therapy. Clinical development2015

Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy.

Ziying Yan, Zoe A Stewart, Patrick L Sinn, John C Olsen, Jim Hu, Paul B McCray, John F Engelhardt

Open access · greenAbstract readReview
In one paragraph

Review in Human gene therapy. Clinical development, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Pulmonary Fibrosis-Focusing on the Future: Aspen Lung Conference 2024 Summary.American journal of respiratory cell and molecular biology · 2025
    Article
  6. Article
  7. A chronicInfection and immunity · 2025
    Article
  8. Review
  9. Strategies for Modifying Adenoviral Vectors for Gene Therapy.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Development and characterization of ferretFrontiers in medicine · 2023
    Article
  15. Article
  16. The Fingerprints of Biomedical Science in Internal Medicine.Advances in experimental medicine and biology · 2022
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ziying Yan1 Department of Anatomy and Cell Biology, University of Iowa School of Medicine , Iowa City, IA 52242.
Zoe A Stewart
Patrick L Sinn
John C Olsen
Jim Hu
Paul B McCray
John F Engelhardt
University of Iowa · USUniversity of North Carolina at Chapel Hill · USUniversity of Toronto · CA

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
Vector CoreP01HL051670 · NHLBI · UNIVERSITY OF IOWA · PI SINN, PATRICK L · 1993 to 2019
$36.5M
Respiratory virus infection in early cystic fibrosis lung diseaseP01HL091842 · NHLBI · UNIVERSITY OF IOWA · PI ZABNER, JOSEPH · 2008 to 2022
$34.2M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Amy Leanne Ryan · 1998 to 2026
$30.5M
Early Pathogenesis of Cystic Fibrosis Related DiabetesR24DK096518 · NIDDK · UNIVERSITY OF IOWA · PI ENGELHARDT, JOHN F, MORAN, ANTOINETTE M. · 2012 to 2018
$10.1M
National Ferret Resource and Research Center on Lung DiseaseR24HL123482 · NHLBI · UNIVERSITY OF IOWA · PI ENGELHARDT, JOHN F · 2014 to 2018
$3.8M
rAAV-directed gene therapy to the lung in cystic fibrosis ferret modelsR01HL108902 · NHLBI · UNIVERSITY OF IOWA · PI ENGELHARDT, JOHN F · 2011 to 2014
$2.2M
Pathobiology of Cystic Fibrosis-Related Diabetes in a Ferret ModelK08DK092284 · NIDDK · UNIVERSITY OF IOWA · PI STEWART, ZOE · 2011 to 2013
$443k
Canadian Institutes of Health ResearchNHLBI NIH HHS HL108902NHLBI NIH HHS HL123482NHLBI NIH HHS P01 HL051670NHLBI NIH HHS P01 HL091842NHLBI NIH HHS R01 HL108902NHLBI NIH HHS R24 HL123482NIDDK NIH HHS DK054759NIDDK NIH HHS DK092284NIDDK NIH HHS DK096518NIDDK NIH HHS P30 DK054759NIDDK NIH HHS R24 DK096518NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

Large animal models of genetic diseases are rapidly becoming integral to biomedical research as technologies to manipulate the mammalian genome improve. The creation of cystic fibrosis (CF) ferrets and pigs is an example of such progress in animal modeling, with the disease phenotypes in the ferret and pig models more reflective of human CF disease than mouse models. The ferret and pig CF models also provide unique opportunities to develop and assess the effectiveness of gene and cell therapies to treat affected organs. In this review, we examine the organ disease phenotypes in these new CF models and the opportunities to test gene therapies at various stages of disease progression in affected organs. We then discuss the progress in developing recombinant replication-defective adenoviral, adeno-associated viral, and lentiviral vectors to target genes to the lung and pancreas in ferrets and pigs, the two most affected organs in CF. Through this review, we hope to convey the potential of these new animal models for developing CF gene and cell therapies.

Indexed as

Disease Models, AnimalFerretsGenetic TherapySwineAnimalsCystic FibrosisGenetic VectorsLungPancreas

Identifiers

PMID25675143
PMCPMC4367511
OpenAlexW2323323362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.